Cardio Diagnostics Statistics
Share Statistics
Cardio Diagnostics has 52.15M
shares outstanding. The number of shares has increased by 0.08%
in one year.
| Shares Outstanding | 52.15M |
| Shares Change (YoY) | 0.08% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 44,380 |
| FTD / Avg. Volume | 3.73% |
Short Selling Information
The latest short interest is 1.31M, so 2.5% of the outstanding
shares have been sold short.
| Short Interest | 1.31M |
| Short % of Shares Out | 2.5% |
| Short % of Float | 2.7% |
| Short Ratio (days to cover) | 1.53 |
Valuation Ratios
The PE ratio is -2.94 and the forward
PE ratio is -0.28.
Cardio Diagnostics's PEG ratio is
0.06.
| PE Ratio | -2.94 |
| Forward PE | -0.28 |
| PS Ratio | 706.81 |
| Forward PS | 11.2 |
| PB Ratio | 2.58 |
| P/FCF Ratio | -4.74 |
| PEG Ratio | 0.06 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardio Diagnostics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.92,
with a Debt / Equity ratio of 0.07.
| Current Ratio | 13.92 |
| Quick Ratio | 13.92 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.08 |
| Debt / FCF | -0.13 |
| Interest Coverage | -448.81 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2,683.85 |
| Profits Per Employee | $-644,880.92 |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -78% in the
last 52 weeks. The beta is 3.65, so Cardio Diagnostics's
price volatility has been higher than the market average.
| Beta | 3.65 |
| 52-Week Price Change | -78% |
| 50-Day Moving Average | 11.74 |
| 200-Day Moving Average | 13.27 |
| Relative Strength Index (RSI) | 31.57 |
| Average Volume (20 Days) | 1,191,004 |
Income Statement
In the last 12 months, Cardio Diagnostics had revenue of 34.89K
and earned -8.38M
in profits. Earnings per share was -0.34.
| Revenue | 34.89K |
| Gross Profit | -241.46K |
| Operating Income | -8.37M |
| Net Income | -8.38M |
| EBITDA | -8.09M |
| EBIT | -8.36M |
| Earnings Per Share (EPS) | -0.34 |
Full Income StatementBalance Sheet
The company has 7.83M in cash and 663.1K in
debt, giving a net cash position of 7.16M.
| Cash & Cash Equivalents | 7.83M |
| Total Debt | 663.1K |
| Net Cash | 7.16M |
| Retained Earnings | -22.75M |
| Total Assets | 10.62M |
| Working Capital | 8.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -4.99M
and capital expenditures -214.77K, giving a free cash flow of -5.21M.
| Operating Cash Flow | -4.99M |
| Capital Expenditures | -214.77K |
| Free Cash Flow | -5.21M |
| FCF Per Share | -0.19 |
Full Cash Flow StatementMargins
Gross margin is -692.05%, with operating and profit margins of -23977.86% and -24028.24%.
| Gross Margin | -692.05% |
| Operating Margin | -23977.86% |
| Pretax Margin | -24028.24% |
| Profit Margin | -24028.24% |
| EBITDA Margin | -23182.77% |
| EBIT Margin | -23977.86% |
| FCF Margin | -14926.54% |
